Lisa Harding, MD, urges psychiatrists to gather histories, deprescribe safely, and send focused sleep referrals now that orexin agonists have arrived for narcolepsy.
|Slideshows|December 13, 2022
Sleep in America
Author(s)Psychiatric Times Editors
Survey results shed light on the effects of insomnia and obstacles to effective treatment.
Advertisement
Advertisement
Related to this article
Advertisement
Advertisement
Trending on Psychiatric Times
1
Real-World Data Link LAI Risperidone to Fewer Emergency Visits in Schizophrenia, Improved Bipolar Treatment
2
ACNP Position Paper Lays Out Roadmap for Biomarker-Guided Psychiatric Drug Trials
3
Nature vs Nurture: The Interplay Between Genetics and Environmental Influences
4
From Side Effect to Target: Rethinking Metabolic Dysfunction in Psychiatry
5